HRP20210759T1 - Poboljšana molekula polipeptida dvostruke specifičnosti - Google Patents

Poboljšana molekula polipeptida dvostruke specifičnosti Download PDF

Info

Publication number
HRP20210759T1
HRP20210759T1 HRP20210759TT HRP20210759T HRP20210759T1 HR P20210759 T1 HRP20210759 T1 HR P20210759T1 HR P20210759T T HRP20210759T T HR P20210759TT HR P20210759 T HRP20210759 T HR P20210759T HR P20210759 T1 HRP20210759 T1 HR P20210759T1
Authority
HR
Croatia
Prior art keywords
seq
polypeptide
domain
molecule
polypeptide molecule
Prior art date
Application number
HRP20210759TT
Other languages
English (en)
Croatian (hr)
Inventor
Martin Hofmann
Felix UNVERDORBEN
Sebastian Bunk
Dominik Maurer
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102017115966.5A external-priority patent/DE102017115966A1/de
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority claimed from PCT/EP2018/069157 external-priority patent/WO2019012141A1/en
Publication of HRP20210759T1 publication Critical patent/HRP20210759T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/626—Diabody or triabody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20210759TT 2017-07-14 2018-07-13 Poboljšana molekula polipeptida dvostruke specifičnosti HRP20210759T1 (hr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762532713P 2017-07-14 2017-07-14
DE102017115966.5A DE102017115966A1 (de) 2017-07-14 2017-07-14 Polypeptidmolekül mit verbesserter zweifacher Spezifität
DE102017119866 2017-08-30
US201862658318P 2018-04-16 2018-04-16
DE102018108995 2018-04-16
PCT/EP2018/069157 WO2019012141A1 (en) 2017-07-14 2018-07-13 IMPROVED POLYPEPTIDE MOLECULE WITH DOUBLE SPECIFICITY
EP18740829.9A EP3652215B1 (en) 2017-07-14 2018-07-13 Improved dual specificity polypeptide molecule

Publications (1)

Publication Number Publication Date
HRP20210759T1 true HRP20210759T1 (hr) 2021-06-11

Family

ID=70848164

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20210759TT HRP20210759T1 (hr) 2017-07-14 2018-07-13 Poboljšana molekula polipeptida dvostruke specifičnosti

Country Status (6)

Country Link
JP (1) JP2021019626A (enrdf_load_stackoverflow)
CL (2) CL2020000097A1 (enrdf_load_stackoverflow)
HR (1) HRP20210759T1 (enrdf_load_stackoverflow)
IL (2) IL272045B1 (enrdf_load_stackoverflow)
PH (2) PH12020500098A1 (enrdf_load_stackoverflow)
ZA (1) ZA202000636B (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX383596B (es) * 2013-03-14 2025-03-14 Macrogenics Inc Moleculas biespecificas que son inmunorreactivas con celulas efectoras inmunes que expresan un receptor activador y un antigeno expresado por una celula infectada por un virus y usos de las mismas.

Also Published As

Publication number Publication date
CL2020000097A1 (es) 2020-05-29
CL2020000098A1 (es) 2020-05-29
IL272045B1 (en) 2025-06-01
PH12020500098A1 (en) 2020-12-07
PH12020500095A1 (en) 2020-12-07
ZA202000636B (en) 2021-07-28
IL272046A (en) 2020-03-31
JP2021019626A (ja) 2021-02-18
IL272045A (en) 2020-03-31

Similar Documents

Publication Publication Date Title
HRP20211744T1 (hr) Poboljšana molekula polipeptida dvostruke specifičnosti
JP2020530762A5 (enrdf_load_stackoverflow)
JP2019023184A5 (enrdf_load_stackoverflow)
Gorman et al. Reshaping a therapeutic CD4 antibody.
Galandrini et al. Antibodies to CD44 trigger effector functions of human T cell clones.
GB2611448A (en) Polypeptide useful in adoptive cell therapy
CA3110837A1 (en) Genetically engineered hematopoietic stem cells and uses thereof
US20230183344A1 (en) T-cell bispecific binding proteins
JP2019525771A5 (enrdf_load_stackoverflow)
CA3199447A1 (en) Fusions with cd8 antigen binding molecules for modulating immune cell function
CN102958942A (zh) 异二聚体结合蛋白及其应用
JPWO2021239812A5 (enrdf_load_stackoverflow)
US20220193137A1 (en) Modified immune receptor constructs
US20240254228A1 (en) Binding molecules
JPWO2020228824A5 (enrdf_load_stackoverflow)
HRP20210759T1 (hr) Poboljšana molekula polipeptida dvostruke specifičnosti
AU678144B2 (en) ICAMs immunoglobulin constant region soluble fusion proteins
JP2021019626A5 (enrdf_load_stackoverflow)
TH2001000191A (th) โมเลกุลโพลีเปปไทด์ความจำเพาะคู่ที่ปรับปรุง
JPWO2022233956A5 (enrdf_load_stackoverflow)
EP4514841A1 (en) Mammalian display platform for multispecific antigen binding proteins
JPWO2020006568A5 (enrdf_load_stackoverflow)
HK40071054A (en) Improved dual specificity polypeptide molecule
KR20250133716A (ko) Piwil1 펩타이드-hla 복합체에 대한 결합 분자
KR20250133715A (ko) Prame 펩타이드-hla 복합체에 대한 결합 분자